Downregulation of GLP–1 and GIP Receptor Expression by Hyperglycemia: 
Possible Contribution to Impaired Incretin Effects in Diabetes. Diabetes. 
2007; 56(6): 1551-9 
77. Faerch K, A Vaag, JJ Holst, C Glumer, et al. Impaired Fasting Glycaemia vs 
Impaired Glucose Tolerance: Similar Impairment of Pancreatic Alpha and 
Beta Cell Function but Differential Roles of  Incretin Hormones and Insulin 
Action. Diabetologia. 2008;51(5):583-61 
78. Drucker DJ. Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 
Diabetes. Diabetes Care. 2007;30(6):1335-43. 
79. Micromedex Solutions. Exenatide. http://www.micromedexsolutions. 
com.ezproxy.uthsc.edu. Accessed July 9, 2014 
80. Davies MJ, D’Alessio DA, Fradkin J, Kernan WN. Mathieu C, Mingrone G, 
et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus 
Report by the American Diabetes Association (ADA) and the